Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1561-1570 of 9367

Page
per page
  1. EC 144
    B4920 EC 144
    Target: HSP90
    Summary: High affinity, potent and selective Hsp90 inhibitor
      <41.39 mg/mL
  2. CCG 203971
    B4921 CCG 203971
     1 Citation
    Summary: Antifibrotic agent
      Soluble in DMSO
  3. IWP 4
    B4922 IWP 4
    Summary: A potent inhibitor of Wnt production
      insoluble in H2O; insoluble in EtOH; insoluble in DMSO
  4. TA 01
    B4923 TA 01
    Summary: CK1ε, CK1δ,and p38α inhibitor
      insoluble in H2O; insoluble in EtOH; ≥12.75 mg/mL
  5. TA 02
    B4924 TA 02
    Summary: p38 MAPK inhibitor
      insoluble in H2O; ≥12.65 mg/mL
  6. C34
    B4925 C34
    Summary: TLR4 inhibitor
      Soluble in DMSO
  7. ML 240
    B4926 ML 240
    Summary: ATP-competitive inhibitor of p97 ATPase
      Soluble in DMSO
  8. CE3F4
    B4927 CE3F4
    Summary: Uncompetitive Epac1 inhibitor
      Soluble in DMSO
  9. CVT 10216
    B4928 CVT 10216
    Summary: reversible inhibitor of aldehyde dehydrogenase 2 (ALDH2)
      ≥52.4 mg/mL
  10. GSK 2837808A
    B4929 GSK 2837808A
    Target: Lactate Dehydrogenases (LDH)
    Summary: Potent, selective lactate dehydrogenase A (LDHA) inhibitor
      ≥9.12 mg/mL

Items 1561-1570 of 9367

Page
per page